{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:33:52Z","timestamp":1777390432324,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1A6A1A03010528"],"award-info":[{"award-number":["2016R1A6A1A03010528"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00417-019-04426-8","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:03:51Z","timestamp":1564560231000},"page":"2155-2161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence"],"prefix":"10.1007","volume":"257","author":[{"given":"Wookyung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirinae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9997","authenticated-orcid":false,"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"issue":"12","key":"4426_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87(12):1453\u20131458","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"4426_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ajo.2004.01.043","volume":"137","author":"M Taban","year":"2004","unstructured":"Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137(6):1073\u20131080. \nhttps:\/\/doi.org\/10.1016\/j.ajo.2004.01.043","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4426_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","volume":"121","author":"JI Lim","year":"2014","unstructured":"Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF, Macula Society Csc Collaborative Study Group R, Education C, Website C (2014) Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 121(5):1073\u20131078. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2013.11.040","journal-title":"Ophthalmology"},{"issue":"10","key":"4426_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Group ToA-rMDWPTTS","year":"1999","unstructured":"Group ToA-rMDWPTTS (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Arch Ophthalmol 117(10):1329\u20131345","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"4426_CR5","first-page":"198","volume":"119","author":"Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study G","year":"2001","unstructured":"Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study G (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119(2):198\u2013207","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"4426_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103\u2013126. \nhttps:\/\/doi.org\/10.1016\/j.survophthal.2012.07.004","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"4426_CR7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/eye.2014.134","volume":"28","author":"OC Erikitola","year":"2014","unstructured":"Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S (2014) Photodynamic therapy for central serous chorioretinopathy. Eye (Lond) 28(8):944\u2013957. \nhttps:\/\/doi.org\/10.1038\/eye.2014.134","journal-title":"Eye (Lond)"},{"key":"4426_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","volume":"170","author":"FH Lai","year":"2016","unstructured":"Lai FH, Ng DS, Bakthavatsalam M, Chan VC, Young AL, Luk FO, Tsang CW, Brelen ME (2016) A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 170:91\u201399. \nhttps:\/\/doi.org\/10.1016\/j.ajo.2016.07.026","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"4426_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bjo.2006.090282","volume":"90","author":"TY Lai","year":"2006","unstructured":"Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90(7):869\u2013874. \nhttps:\/\/doi.org\/10.1136\/bjo.2006.090282","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4426_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IAE.0b013e318280769c","volume":"33","author":"E Smretschnig","year":"2013","unstructured":"Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S (2013) Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina 33(2):316\u2013323. \nhttps:\/\/doi.org\/10.1097\/IAE.0b013e318280769c","journal-title":"Retina"},{"issue":"8","key":"4426_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","volume":"112","author":"DR Guyer","year":"1994","unstructured":"Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112(8):1057\u20131062","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"4426_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","volume":"121","author":"C Prunte","year":"1996","unstructured":"Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121(1):26\u201334","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4426_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pdpdt.2014.07.005","volume":"11","author":"R Hua","year":"2014","unstructured":"Hua R, Liu L, Li C, Chen L (2014) Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels. Photodiagn Photodyn Ther 11(4):519\u2013525. \nhttps:\/\/doi.org\/10.1016\/j.pdpdt.2014.07.005","journal-title":"Photodiagn Photodyn Ther"},{"issue":"9","key":"4426_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","volume":"36","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A (2016) Choroidal vascularity index in central serous chorioretinopathy. Retina 36(9):1646\u20131651. \nhttps:\/\/doi.org\/10.1097\/IAE.0000000000001040","journal-title":"Retina"},{"issue":"4","key":"4426_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bjophthalmol-2016-308921","volume":"101","author":"T Izumi","year":"2017","unstructured":"Izumi T, Koizumi H, Maruko I, Takahashi Y, Sonoda S, Sakamoto T, Iida T (2017) Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br J Ophthalmol 101(4):433\u2013437. \nhttps:\/\/doi.org\/10.1136\/bjophthalmol-2016-308921","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"4426_CR16","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1097\/IAE.0b013e3182252aa8","volume":"31","author":"A Shinojima","year":"2011","unstructured":"Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M (2011) Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Retina 31(9):1912\u20131920. \nhttps:\/\/doi.org\/10.1097\/IAE.0b013e3182252aa8","journal-title":"Retina"},{"issue":"11","key":"4426_CR17","first-page":"1062","volume":"116","author":"I Maruko","year":"2012","unstructured":"Maruko I (2012) Evaluation of the choroid in central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi 116(11):1062\u20131079","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"3","key":"4426_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3928\/23258160-20180221-07","volume":"49","author":"R Tan","year":"2018","unstructured":"Tan R, Agrawal R, Taduru S, Gupta A, Vupparaboina K, Chhablani J (2018) Choroidal vascularity index in retinitis pigmentosa: an OCT study. Ophthalmic Surg Lasers Imaging Retina 49(3):191\u2013197. \nhttps:\/\/doi.org\/10.3928\/23258160-20180221-07","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"4426_CR19","doi-asserted-by":"publisher","first-page":"e0163104","DOI":"10.1371\/journal.pone.0163104","volume":"11","author":"T Kinoshita","year":"2016","unstructured":"Kinoshita T, Mitamura Y, Mori T, Akaiwa K, Semba K, Egawa M, Mori J, Sonoda S, Sakamoto T (2016) Changes in choroidal structures in eyes with chronic central serous chorioretinopathy after half-dose photodynamic therapy. PLoS One 11(9):e0163104. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0163104","journal-title":"PLoS One"},{"issue":"6","key":"4426_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","volume":"23","author":"F Cardillo Piccolino","year":"2003","unstructured":"Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23(6):752\u2013763","journal-title":"Retina"},{"issue":"3","key":"4426_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","volume":"23","author":"LA Yannuzzi","year":"2003","unstructured":"Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23(3):288\u2013298","journal-title":"Retina"},{"issue":"3","key":"4426_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","volume":"153","author":"M Nicolo","year":"2012","unstructured":"Nicolo M, Zoli D, Musolino M, Traverso CE (2012) Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy. Am J Ophthalmol 153(3):474\u2013480 e471. \nhttps:\/\/doi.org\/10.1016\/j.ajo.2011.08.015","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4426_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","volume":"157","author":"M Nicolo","year":"2014","unstructured":"Nicolo M, Eandi CM, Alovisi C, Grignolo FM, Traverso CE, Musetti D, Cardillo Piccolino F (2014) Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 157(5):1033\u20131037. \nhttps:\/\/doi.org\/10.1016\/j.ajo.2014.01.022","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4426_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","volume":"122","author":"K Fujita","year":"2015","unstructured":"Fujita K, Imamura Y, Shinoda K, Matsumoto CS, Mizutani Y, Hashizume K, Mizota A, Yuzawa M (2015) One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 122(3):555\u2013561. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2014.09.034","journal-title":"Ophthalmology"},{"issue":"10","key":"4426_CR25","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115(10):1756\u20131765. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2008.04.014","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04426-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:31:43Z","timestamp":1596065503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04426-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4426"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04426-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"23 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and\/or National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}